Health Canada warns of mix-up between high and low blood pressure pills

Health Canada has issued a public advisory and recall notice after learning that some medications labelled as treatment for ...
Inside Halton

Health Canada issues public advisory for recalled blood pressure medication

Health Canada has issued a recall notice and public advisory for two lots of the blood pressure medication MAR-Amlodipine 5 mg, as some bottles may contain the wrong tablets.

Health Canada recalls high blood pressure medication over possible mix-up

Health Canada is warning Canadians to check their prescriptions after two lots of MAR Amlodipine 5 mg tablets were recalled. Marcan Pharmaceuticals says some bottles may contain a different drug used ...

Liberals revive bill to allow health records to be shared across Canada

Amid the stories of Canadian patients falling through the cracks of the health-care system, the federal government is ...

Why drug approval in Canada should not rely on foreign regulators

Without much fanfare, Health Canada announced in the Canada Gazette Part 1 on Dec. 22, 2025 that it was beginning a 70-day ...
JD Supra

Health Canada proposes to amend the Food and Drug Regulations and Medical Devices Regulations to address shortages

On December 28, 2024, Health Canada published proposed amendments to the Food and Drug Regulations and Medical Devices Regulations to address therapeutic product shortages (see our previous article ...
JD Supra

Health Canada publishes guidance on submitting risk management plans

As we previously reported, agile licensing amendments to the Food and Drug Regulations and Medical Devices Regulations were registered on November 29, 2024. We are continuing to update our previous ...